Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1995. Start Trial.
Date Value
June 30, 2026 156.10M
March 31, 2026 156.52M
December 31, 2025 155.88M
September 30, 2025 155.75M
June 30, 2025 154.97M
March 31, 2025 156.76M
December 31, 2024 157.92M
September 30, 2024 158.88M
June 30, 2024 158.22M
March 31, 2024 157.55M
December 31, 2023 157.14M
September 30, 2023 158.35M
June 30, 2023 157.64M
March 31, 2023 157.34M
December 31, 2022 157.09M
September 30, 2022 156.93M
June 30, 2022 156.64M
March 31, 2022 157.05M
December 31, 2021 157.28M
September 30, 2021 157.09M
June 30, 2021 155.82M
March 31, 2021 155.42M
December 31, 2020 155.06M
September 30, 2020 154.40M
June 30, 2020 153.81M
Date Value
March 31, 2020 152.49M
December 31, 2019 153.13M
September 30, 2019 152.34M
June 30, 2019 151.74M
March 31, 2019 151.25M
December 31, 2018 150.94M
September 30, 2018 151.21M
June 30, 2018 150.43M
March 31, 2018 150.18M
December 31, 2017 149.88M
September 30, 2017 149.64M
June 30, 2017 149.42M
March 31, 2017 149.33M
December 31, 2016 149.24M
September 30, 2016 149.21M
June 30, 2016 149.02M
March 31, 2016 148.79M
December 31, 2015 148.77M
September 30, 2015 148.73M
June 30, 2015 148.61M
March 31, 2015 148.61M
December 31, 2014 148.44M
September 30, 2014 148.12M
June 30, 2014 148.01M
March 31, 2014 147.70M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Repligen Corp. 56.43M
BioLife Solutions, Inc. 48.89M
MindWalk Holdings Corp. 46.99M
Maravai Lifesciences Holdings, Inc. 148.89M
MaxCyte, Inc. 106.13M